Skip to main content
Beginner 2 min read

What Does PD-L1 TPS Mean?

PD-L1 TPS explained for patients: what it is, why it may affect treatment options, and what to ask about testing.

Source:FDA — Pembrolizumab first-line indication for NSCLC with TPS ≥1%

Review status: AI-assisted, editorial review complete. Not reviewed by a clinician. How we check pages

The short answer

PD-L1 TPS is a biomarker result. It means a tumor proportion score for PD-L1 staining. In some cancers, biomarker results can help guide targeted therapy, immunotherapy, or clinical trial options, but the result only matters in context.

  • PD-L1 TPS is a biomarker or molecular result, not a treatment decision by itself.

  • It can be relevant in some lung cancer immunotherapy decisions.

  • A positive result may or may not change treatment depending on cancer type, stage, prior treatment, and available options.

  • Ask whether the result is from tumor testing, blood testing, inherited genetic testing, or another method.

Choose how you want to read this

The whole article, with every detail and caution.

The short answer

TPS stands for tumor proportion score. It is a PD-L1 result reported on a lung cancer pathology report as a percentage. Ask your team to explain exactly how your score was measured.

Where it may be relevant

The FDA describes PD-L1 TPS in the approval of pembrolizumab (Keytruda) for non-small cell lung cancer. Not everyone with lung cancer needs, or benefits from, the same testing or treatment.

Why it can affect treatment options

The National Cancer Institute explains that some tumors produce a lot of PD-L1. PD-L1 binding to PD-1 keeps T cells from killing tumor cells. Immune checkpoint inhibitors block that link so T cells can attack.

The FDA approved pembrolizumab in April 2019 as first-line treatment for stage III or metastatic non-small cell lung cancer in people who:

  • have no EGFR or ALK changes in the tumor, and
  • have a PD-L1 TPS of 1% or higher.

The FDA notes that PD-L1 was measured in the pivotal trial with a specific test, the PD-L1 IHC 22C3 pharmDx kit. So the number on your report belongs with the test that produced it. A TPS is one input. It is not the treatment decision on its own.

Is this urgent?

A TPS result is not an emergency. It is one input your oncology team weighs, along with your stage, other biomarker results, and your overall health. This usually happens before systemic treatment begins.

Questions to ask

  • What is my exact TPS score, and which test produced it?
  • Is pembrolizumab, alone or with other treatment, being recommended, and why?
  • Has my tumor also been tested for EGFR, ALK, and other biomarkers?
  • What is the plan if my TPS is low?

Sources

Clinician holds a tablet toward a seated woman at a desk as they talk in a bright office.

Common questions

What is PD-L1 TPS?

PD-L1 TPS means a tumor proportion score for PD-L1 staining. It is one type of result that may appear on a biomarker, molecular, genomic, or pathology report.

Can it affect treatment?

Sometimes. Certain biomarkers can point toward targeted therapy, immunotherapy, or a clinical trial, but the same result can mean different things in different cancers.

What should I ask my oncologist?

Ask whether the result is actionable for your cancer, whether a matched treatment exists, and whether a trial is relevant.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Look up more plain-language explanations for report wording.

Decode another report term
Talk to a person

Talk with a trained specialist or navigator

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Prepared by Cancer Explained's AI-assisted editorial system

Written from federal health agency material and compared with the source cited below.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-07-30 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30

Review details and limits

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

More on this topic

Words to know

Tap any term to see what it means.

Browse the full glossary →

Knowledge check

0 of 3 answered

  1. Q1.PD-L1 TPS is best understood as...
  2. Q2.What can biomarker testing sometimes help select?
  3. Q3.What is a useful question about a biomarker result?

This self-assessment checks understanding of educational content only. It is not medical advice.

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.